𝔖 Bobbio Scriptorium

✦ LIBER ✦

Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial

Book ID: 117299273
Publisher: The Lancet
Year: 2006
Tongue: English
Weight: 337 KB
Volume: 367
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(06)68734-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Aspirin plus dipyridamole versus aspirin

Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT) : randomized controlled trial

✍ Schmidt, C. 📂 Article 📅 2006 🏛 Masson Editeur 🌐 French ⚖ 52 KB

Medium intensity oral anticoagulants ver

Medium intensity oral anticoagulants versus aspirin after cerebral ischaemia of arterial origin (ESPRIT): a randomised controlled trial

✍ A Algra 📂 Article 📅 2007 🏛 The Lancet 🌐 English ⚖ 189 KB

A randomized trial of anticoagulants ver

A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial origin

📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 906 KB

Clopidogrel plus aspirin versus aspirin

Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR study): a randomised, open-label, blinded-endpoint trial

✍ Ka Sing Lawrence Wong; Christopher Chen; Jianhui Fu; Hui Meng Chang; Nijasri C S 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 255 KB

Thrombelastographic haemostatic status a

Thrombelastographic haemostatic status and antiplatelet therapy after coronary artery bypass surgery (TEG-CABG trial): assessing and monitoring the antithrombotic effect of clopidogrel and aspirin versus aspirin alone in hypercoagulable patients: study protocol for a randomized controlled trial

✍ Sulman Rafiq, Pär Ingemar Johansson, Mette Zacho, Trine Stissing, Klaus Kofoed, 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 318 KB

Effects of aspirin plus extended-release

Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study

✍ Hans-Christoph Diener; Ralph L Sacco; Salim Yusuf; Daniel Cotton; Stephanie Ôunp 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 191 KB